Osterweis Capital Management Inc. purchased a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 12,542 shares of the pharmacy operator’s stock, valued at approximately $915,000.
Several other hedge funds and other institutional investors have also bought and sold shares of WBA. Asset Dedication LLC boosted its stake in Walgreens Boots Alliance by 204.6% during the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after purchasing an additional 1,060 shares during the period. BlueMountain Capital Management LLC acquired a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $103,000. CSat Investment Advisory L.P. acquired a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $104,000. Capital Advisors Ltd. LLC boosted its stake in Walgreens Boots Alliance by 1,150.3% during the 3rd quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock valued at $150,000 after purchasing an additional 1,898 shares during the period. Finally, Livingston Group Asset Management CO operating as Southport Capital Management acquired a new position in Walgreens Boots Alliance during the 3rd quarter valued at about $154,000. 62.59% of the stock is owned by institutional investors and hedge funds.
WBA stock opened at $82.55 on Thursday. Walgreens Boots Alliance Inc has a 52 week low of $59.07 and a 52 week high of $86.31. The stock has a market cap of $78.61 billion, a price-to-earnings ratio of 13.71, a P/E/G ratio of 1.29 and a beta of 0.76. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The company had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. On average, research analysts expect that Walgreens Boots Alliance Inc will post 6.54 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be given a dividend of $0.44 per share. The ex-dividend date is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.13%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.
In related news, Director Nancy M. Schlichting sold 7,050 shares of the business’s stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total value of $555,610.50. Following the sale, the director now directly owns 5,709 shares in the company, valued at approximately $449,926.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now owns 81,076 shares in the company, valued at $6,386,356.52. The disclosure for this sale can be found here. Insiders sold a total of 73,756 shares of company stock worth $5,824,194 over the last quarter. Insiders own 14.80% of the company’s stock.
A number of research analysts have issued reports on WBA shares. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a research note on Tuesday, September 25th. ValuEngine raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, September 21st. Robert W. Baird boosted their target price on shares of Walgreens Boots Alliance from $64.00 to $69.00 and gave the company a “neutral” rating in a research note on Tuesday, September 11th. Citigroup boosted their target price on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. Finally, Loop Capital boosted their price target on shares of Walgreens Boots Alliance from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, October 12th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating, six have given a buy rating and two have issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $78.89.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/12/06/osterweis-capital-management-inc-purchases-shares-of-12542-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: What are the risks of holding treasury bonds?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.